198 related articles for article (PubMed ID: 26819049)
1. Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma.
Yoo HY; Kim P; Kim WS; Lee SH; Kim S; Kang SY; Jang HY; Lee JE; Kim J; Kim SJ; Ko YH; Lee S
Haematologica; 2016 Jun; 101(6):757-63. PubMed ID: 26819049
[TBL] [Abstract][Full Text] [Related]
2. Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions.
Yoshida N; Shigemori K; Donaldson N; Trevisani C; Cordero NA; Stevenson KE; Bu X; Arakawa F; Takeuchi M; Ohshima K; Yoda A; Ng SY; Weinstock DM
Blood; 2020 Apr; 135(17):1467-1471. PubMed ID: 31961925
[TBL] [Abstract][Full Text] [Related]
3. Author reply to Comment on: Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma, by Yoo et al.
Yoo HY; Kim P; Kim WS; Lee SH; Kim S; Kang SY; Jang HY; Lee JE; Kim J; Kim SJ; Ko YH; Lee S
Haematologica; 2016 Jun; 101(6):e271. PubMed ID: 27252517
[No Abstract] [Full Text] [Related]
4. Mice transgenic for human
Lee GJ; Jun Y; Jeon YK; Lee D; Lee S; Kim J
Oncoimmunology; 2022; 11(1):2015170. PubMed ID: 35003894
[No Abstract] [Full Text] [Related]
5. Comment on: Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma, by Yoo et al.
Gong Q; Wang C; Rohr J; Feldman AL; Chan WC; McKeithan TW
Haematologica; 2016 Jun; 101(6):e269-70. PubMed ID: 27252516
[No Abstract] [Full Text] [Related]
6. Altered expression of CTLA-4, CD28, VDR, and CD45 mRNA in T cells of patients with Hashimoto's thyroiditis - a pilot study.
Tokić S; Štefanić M; Karner I; Glavaš-Obrovac L
Endokrynol Pol; 2017; 68(3):274-828. PubMed ID: 28660994
[TBL] [Abstract][Full Text] [Related]
7. Adoptive transfer of murine T cells expressing a chimeric-PD1-Dap10 receptor as an immunotherapy for lymphoma.
Lynch A; Hawk W; Nylen E; Ober S; Autin P; Barber A
Immunology; 2017 Nov; 152(3):472-483. PubMed ID: 28670716
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of acquired CD28 mutations identified in cutaneous T cell lymphoma.
Gmyrek GB; Pingel J; Choi J; Green JM
Cell Immunol; 2017 Sep; 319():28-34. PubMed ID: 28711152
[TBL] [Abstract][Full Text] [Related]
9. Positive conversion of negative signaling of CTLA4 potentiates antitumor efficacy of adoptive T-cell therapy in murine tumor models.
Shin JH; Park HB; Oh YM; Lim DP; Lee JE; Seo HH; Lee SJ; Eom HS; Kim IH; Lee SH; Choi K
Blood; 2012 Jun; 119(24):5678-87. PubMed ID: 22538857
[TBL] [Abstract][Full Text] [Related]
10. Recurrent activating mutations of CD28 in peripheral T-cell lymphomas.
Rohr J; Guo S; Huo J; Bouska A; Lachel C; Li Y; Simone PD; Zhang W; Gong Q; Wang C; Cannon A; Heavican T; Mottok A; Hung S; Rosenwald A; Gascoyne R; Fu K; Greiner TC; Weisenburger DD; Vose JM; Staudt LM; Xiao W; Borgstahl GE; Davis S; Steidl C; McKeithan T; Iqbal J; Chan WC
Leukemia; 2016 May; 30(5):1062-70. PubMed ID: 26719098
[TBL] [Abstract][Full Text] [Related]
11. Detection of Gene Fusion Transcripts in Peripheral T-Cell Lymphoma Using a Multiplexed Targeted Sequencing Assay.
Drieux F; Ruminy P; Sater V; Marchand V; Fataccioli V; Lanic MD; Viennot M; Viailly PJ; Sako N; Robe C; Dupuy A; Vallois D; Veresezan L; Poullot E; Picquenot JM; Bossard C; Parrens M; Lemonnier F; Jardin F; de Leval L; Gaulard P
J Mol Diagn; 2021 Aug; 23(8):929-940. PubMed ID: 34147695
[TBL] [Abstract][Full Text] [Related]
12. Recent Progress in the Understanding of Angioimmunoblastic T-cell Lymphoma.
Fujisawa M; Chiba S; Sakata-Yanagimoto M
J Clin Exp Hematop; 2017; 57(3):109-119. PubMed ID: 29279549
[TBL] [Abstract][Full Text] [Related]
13. Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations.
Petit B; Leroy K; Kanavaros P; Boulland ML; Druet-Cabanac M; Haioun C; Bordessoule D; Gaulard P
Hum Pathol; 2001 Feb; 32(2):196-204. PubMed ID: 11230707
[TBL] [Abstract][Full Text] [Related]
14. The mutation of BCOR is highly recurrent and oncogenic in mature T-cell lymphoma.
Kang JH; Lee SH; Lee J; Choi M; Cho J; Kim SJ; Kim WS; Ko YH; Yoo HY
BMC Cancer; 2021 Jan; 21(1):82. PubMed ID: 33468080
[TBL] [Abstract][Full Text] [Related]
15. RNA fusions involving
Vallois D; Dupuy A; Lemonnier F; Allen G; Missiaglia E; Fataccioli V; Ortonne N; Clavert A; Delarue R; Rousselet MC; Fabiani B; Llamas-Gutierrez F; Ogawa S; Thome M; Ko YH; Kataoka K; Gaulard P; de Leval L
Haematologica; 2018 Aug; 103(8):e360-e363. PubMed ID: 29545337
[No Abstract] [Full Text] [Related]
16. Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2.
Ungewickell A; Bhaduri A; Rios E; Reuter J; Lee CS; Mah A; Zehnder A; Ohgami R; Kulkarni S; Armstrong R; Weng WK; Gratzinger D; Tavallaee M; Rook A; Snyder M; Kim Y; Khavari PA
Nat Genet; 2015 Sep; 47(9):1056-60. PubMed ID: 26258847
[TBL] [Abstract][Full Text] [Related]
17. Relationship of CTLA4 and CD28 polymorphisms with lung involvement, HRCT findings and pulmonary function tests in Turkish patients with ankylosing spondylitis.
Karakose Okyaltırık F; Rezvani A; Turan S; Uysal Ö; Yakar F; Sozgen H; Ozkan NE; Akkoyunlu ME; Bayram M; Kutbay Ozcelik H; Sezer M; Guler M; Yaylım İ; Kart L
Clin Respir J; 2017 Sep; 11(5):593-601. PubMed ID: 26365494
[TBL] [Abstract][Full Text] [Related]
18. [Molecular abnormalities in lymphomas].
Delsol G
Bull Cancer; 2010 Nov; 97(11):1347-64. PubMed ID: 21084243
[TBL] [Abstract][Full Text] [Related]
19. CTLA4 Promotes Tyk2-STAT3-Dependent B-cell Oncogenicity.
Herrmann A; Lahtz C; Nagao T; Song JY; Chan WC; Lee H; Yue C; Look T; Mülfarth R; Li W; Jenkins K; Williams J; Budde LE; Forman S; Kwak L; Blankenstein T; Yu H
Cancer Res; 2017 Sep; 77(18):5118-5128. PubMed ID: 28716895
[TBL] [Abstract][Full Text] [Related]
20. Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas.
Boulland ML; Meignin V; Leroy-Viard K; Copie-Bergman C; Brière J; Touitou R; Kanavaros P; Gaulard P
Am J Pathol; 1998 Oct; 153(4):1229-37. PubMed ID: 9777954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]